Global Pharma Companies See Battle For Survival In Pakistan 21/03/2013 by Shahzada Irfan Ahmed for Intellectual Property Watch 3 Comments Lahore, Pakistan – Weak regulation of the local pharmaceutical industry in Pakistan, including non-enforcement of intellectual property rights and the absence of a simple and swift dispute resolution mechanism, have hit the country’s health sector badly, industry sources say.
Pharma, International Red Cross Combine To Fight NCDs 19/03/2013 by Intellectual Property Watch Leave a Comment The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the International Federation of Red Cross and Red Crescent Societies (IFRC) announced on 19 March a two-year partnership on non-communicable diseases.
Tuberculosis: WHO, Global Fund Call For Mobilisation Of Funds As Resistance Rises 18/03/2013 by Catherine Saez, Intellectual Property Watch 2 Comments Tuberculosis is now a renewed threat, with strains that prove resistant to multiple drugs and are transmissible and the potential to spread widely, according to the World Health Organization and the Global Fund, which are looking for US$1.6 billion a year to prevent the spread of the disease.
Nearly 50 Groups Demand IPRs Out Of EU-US FTA 18/03/2013 by Intellectual Property Watch 1 Comment Upwards of 50 civil society groups have issued a declaration asking for the exclusion of all forms of intellectual property rights from the upcoming Trans-Atlantic Free Trade Agreement between the European Union and the United States. They raised significant concerns about the potential effect of IP rights’ inclusion on the public interest in the countries involved.
UN Agencies To Examine International Standards, Potential Value For Developing Countries 18/03/2013 by Catherine Saez, Intellectual Property Watch 1 Comment Five United Nations agencies are joining efforts to tackle the rising issue of private standards which they say are affecting developing countries’ exports by creating market entry hurdles for those countries. A new forum will be launched this week, and will establish its priority issues.
African Ministers Focus On IP Role In Innovation For Development; Less On Flexibilities 18/03/2013 by Rachel Marusak Hermann, Intellectual Property Watch 4 Comments Dar es Salaam, Tanzania – The role of innovation as a driving force of social, economic, and environmental development is one of the central themes in post-2015 global development agenda discussions. In a ministerial-level meeting with guidance from the World Intellectual Property Organization last week, African policymakers outlined what they would need to foster innovation at home. Among a list of recommendations, ministers widely agreed on the importance of developing national intellectual property frameworks, capacity building, and raising awareness through education. Encouraging the use of IP flexibilities, however, was largely left out of the conversation.
On Plant Patents, EPO President Backs Industry, Disregards EU Parliament, Group Says 13/03/2013 by Catherine Saez, Intellectual Property Watch 1 Comment A civil society coalition fighting patents on conventional plants in Europe has published a briefing paper alleging that the European Patent Office is giving a “green light” to patents on plants and animals, disregarding the position of the European Parliament.
Leaked IP Chapter Of India-EU FTA Shows TRIPS-Plus Pitfalls For India, Expert Says 12/03/2013 by Patralekha Chatterjee for Intellectual Property Watch 5 Comments Indian negotiators are reportedly under tremendous pressure to give in to the European demands for a more rigid intellectual property rights regime in the ongoing discussions on EU-India free trade agreement, suggests a leaked draft text of the chapter on IP which is being negotiated.
Digital Rights, Health Concerns As TPP Talks Continue 11/03/2013 by Intellectual Property Watch Leave a Comment As closed-door talks for the Trans-Pacific Partnership (TPP) agreement progress this week, concerns have been raised about the proposed intellectual property chapter. Industry, public health and digital liberties groups urged negotiators to consider the possible impact on investment, digital rights, access to affordable medicines, and R&D for life-saving medicines.
Swiss Perspectives On The Success Of Its National Innovation Model 11/03/2013 by Tiphaine Nunzia Caulier for Intellectual Property Watch Leave a Comment Swiss innovation is internationally recognised for its high quality, and the reasons may derive from its fiscal system, labour market, research and development (R&D) model and education policy, a senior Swiss official has said.